Daily Stock List
AXIM Biotechnologies, Inc. (AXIM)
Promotion Stock Secrets, TopPennyStockMovers, CFN Media Group, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and we report on the Company today, here at the QualityStocks Daily Newsletter.
AXIM Biotechnologies, Inc. is a biotechnology company concentrating on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market innovative solutions via research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. is a major investor in AXIM. AXIM Biotechnologies has its corporate office in New York, New York.
The Company’s emphasis is on inventive proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. AXIM is advancing its patented controlled-release cannabinoid gum in studies covering several indications. Its flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants.
AXIM Biotechnologies’ pipeline of intellectual property (IP) protected cannabinoid-based products also include MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. This pioneering invention is on course to be fully registered by the EMA and FDA by the end of this year. It is the world’s first patented cannabinoid controlled-release chewing gum.
Furthermore, the Company’s products also include RENECANN™ - the world’s first cannabigerol (CBG)-based skincare product line. Also, AXIM’s products include ORAXIMAX™ - the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the reduction of intraocular pressure and for the relief of conjunctivitis.
In May 2016, AXIM Biotechnologies announced that it was launching human dermatological clinical trials based on its proprietary, patent-pending topical ointment formulation AX-1602, which includes the “stem cell cannabinoid” cannabigerol (CBG) and other cannabinoids. The two indications for its AX-1602 in human trials are Psoriasis (PsO) and atopic dermatitis (AD) also called eczema.
Last week, Medical Marijuana, Inc. announced that its major investment company AXIM® Biotechnologies entered clinical trials at Wageningen University in the Netherlands for the treatment of irritable bowel syndrome (IBS) with AXIM's CanChew Plus® cannabidiol (CBD) gum. AXIM recently announced that it received approval from the Medical Ethical Committee (METC) at Wageningen University for the trial using controlled-release hemp oil CBD chewing gum with patients suffering from IBS.
AXIM® Biotechnologies held its second annual board meeting on January 20, 2017 in New York City. Company Board members reviewed milestones in 2016 and discussed clinical trial progress for IBS, MS and psoriasis and eczema (PSO), and additional R&D activities for the next 12 months. Additionally, the meeting approved budgets required to perform the clinical projects and business developments.
AXIM Biotechnologies, Inc. (AXIM), closed Wednesday's trading session at $13.83, up 1.69%, on 41,917 volume with 222 trades. The average volume for the last 60 days is 137,794 and the stock's 52-week low/high is $0.21/$19.80.
Lexaria Bioscience Corp. (LXRP)
SmallCap Network, Wealth Insider Alert, CFN Media Group, StreetAuthority Daily, MassiveStockProfits, AllPennyStocks, Stockgoodies, WealthMakers, BUYINS.NET, and Cannabis Financial Network News reported earlier on Lexaria Bioscience Corp. (LXRP), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Lexaria Bioscience Corp. is a food sciences company listed on the OTCQB. The Company’s focus is on the delivery of active compounds, which can behave as superfoods by way of its proprietary infusion technologies. The Company formerly went by the name Lexaria Corp. It changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience is based in Vancouver, British Columbia.
Lexaria’s technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine, and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. The Company’s focus is on the delivery of hemp oil compounds procured from legal, agricultural hemp seed oil, through gourmet foods products established upon its proprietary infusion technologies.
Moreover, Lexaria Bioscience, via its subsidiary, PoViva Tea LLC, produces and sells hemp oil enriched teas under the ViPova brand name in the United States. ViPova™ Tea is made with a rich, smooth organic black tea from China’s renowned Yunnan Province and premier rich hemp oil derived from the highest quality agricultural hemp cultivars. The Company uses its own patent-pending process to infuse the valuable hemp oil ingredients inside lipids. This allows a more efficient and comforting delivery to one’s body.
Lexaria Bioscience will have its first energy products available soon. Lexaria’s emphasis is an Energy Bar high in protein, but balanced with fiber and the right amount of carbohydrates. Recipe development for its new Lexaria Energy bar is taking place. First-generation prototypes have been produced. As well, the Company is part of a joint venture that has filed an application in Canada to be permitted to grow and sell medical marijuana in Canada under the Marihuana for Medical Purposes Regulations (MMPR) legislation.
Lexaria Bioscience announced in August 2016 that it entered into a Letter of Intent (LOI) to license its proprietary technology to CBDM LLC. This is for the development and sale of a range of marijuana oil infused products in a potentially national-scale launch to Indian reservations across the United States and certain other U.S. territories.
Last week, Lexaria Bioscience and NeutriSci International, Inc. announced the successful development and initial trial of the industry’s first zero-sugar cannabinoid/pterostilbene edible tablet employing Neutrisci’s and Lexaria’s proprietary and patented technologies. NeutriSci specializes in the innovation, production and formulation of nutraceutical products.
Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.587622, up 4.93%, on 381,320 volume with 207 trades. The average volume for the last 60 days is 360,387 and the stock's 52-week low/high is $0.08/$0.699.
Liquidmetal® Technologies, Inc. (LQMT)
Marketbeat, Jason Bond, Promotion Stock Secrets, Penny Pro, Winston Small Cap, Wall Street Mover, SmallCapVoice, PennyStocks24, Pennybuster, SuperNova Elite, Wealth Daily, PennyStocks Forever, and Greenbackers reported earlier on Liquidmetal® Technologies, Inc. (LQMT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Liquidmetal® Technologies, Inc. is the foremost developer of bulk alloys, which use the performance advantages that amorphous alloy technology provides. Amorphous alloys are unique materials distinguished by their ability to retain a random structure when they solidify. This is in comparison to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal® Technologies is headquartered in Rancho Santa Margarita, California where it also has its Manufacturing Center of Excellence.
Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form. This is enabling critical improvements in products across a wide range of industries.
Liquidmetal has two to three times the strength of titanium and stainless steel. It undergoes processing similar to plastics on the Company's proprietary Liquidmetal molding machines. Liquidmetal is processed and solidified in a vitreous or amorphous state (frozen liquid). Liquidmetal® Technologies’ alloys are, in numerous cases, stronger, harder, more elastic, and more wear and corrosion resistant than typically used high-performance alloys.
Liquidmetal Technologies’ "bulk" amorphous alloys possess advantages usually associated with plastics. These include the ability to undergo molding into precision, complex, and highly finished products.
The Company’s class of patented alloys and processes form the basis of high performance materials used in a broad assortment of medical, military, consumer, and industrial, and sporting goods products. Liquidmetal® Technologies controls the intellectual property (IP) rights with greater than 70 U.S. patents.
Liquidmetal® Technologies and the University of Southern California’s M.C. Gill Composites Center are working together to develop an advanced manufacturing process to produce large-scale amorphous metal and fiber laminate sheets for space applications. The work is funded by a NASA SBIR (Small Business Innovation Research) Phase I contract addressing solicitation topic number Z2.01, “Cross cutting advanced manufacturing process for large scale bulk metallic glass systems for aerospace applications.”
This month, Liquidmetal® Technologies announced that it ordered its first amorphous metal molding machine from its Licensee, Eontec Co., Ltd. The design of the machine is based on a die casting platform. It is complementary to the injection molding machine developed with Engel. Delivery of the machine is expected in March 2017.
Today, Liquidmetal® Technologies announced that on January 18, 2017, the Company entered into an agreement for the purchase of a roughly 41,000-square-foot building in Lake Forest, California for about $7.8M. Liquidmetal® Technologies expects to close the property purchase on February 17, 2017.
Liquidmetal® Technologies, Inc. (LQMT), closed Wednesday's trading session at $0.238, up 0.63%, on 4,385,058 volume with 576 trades. The average volume for the last 60 days is 1,853,071 and the stock's 52-week low/high is $0.067/$0.2525.
Solitron Devices, Inc. (SODI)
Stock Profile reported earlier on Solitron Devices, Inc. (SODI), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Solitron Devices, Inc. designs, develops, manufactures and markets solid-state semiconductor components and related devices. These are chiefly for the military and aerospace markets. Most of its products are custom made pursuant to contracts with customers whose end products are sold to the U.S. government. Other products, including Joint Army/Navy transistors, diodes and Standard Military Drawings voltage regulators sell as standard or catalog items. Solitron Devices is headquartered in West Palm Beach, Florida.
Fundamentally, the Company centers on designing and manufacturing high performance, high density, high quality power components and circuitry. Solitron Devices has a reputation for producing custom and standard power solid-state components for the aerospace, defense, industrial, medical, and commercial industries. Its advanced semiconductor device and packaging technology has contributed to the success of largely every U.S. and European aerospace and defense program.
Solitron Devices manufactures a large assortment of bipolar and metal oxide semiconductor (MOS) power transistors, power and control hybrids, junction and power MOS field effect transistors (Power MOSFETS), field effect transistors, as well as other related products. It hybrids are either standard or custom made to meet customer needs.
Solitron Devices provides support to all analog and mixed signal designs, whether they are power or small signal hybrids. The Company considers support of digital and high frequency modules on a case-by-case basis. It supports small, medium and large volume requirements and supports COTS (Commercial Off-The-Shelf) of all products it makes.
The Company is at the vanguard of semiconductor packaging and device thermal management. Over the years, the Company has designed and manufactured over 400 different package styles. Solitron’s capabilities include Space Level Processing; Engineering, Manufacturing; Off-Shore Assembly; and In-House Testing.
The Company is a pioneer and leader in Thick-Film Power Hybrid Technology. Solitron provides a broad array of sophisticated power MOSFETs, BIPOLAR power transistors and SCHOTTKY rectifiers/diodes power hybrid circuits, which incorporate Small Signal, Monolithic Integrated Circuits and Power Semiconductors into a single "mini" package.
Solitron Devices has supplied components for more than 200 Defense and Aerospace programs since 1965. The Company has a 47,000-sq. ft. manufacturing facility housing a 5K sq. ft. Class 10,000 clean room (FED-STD-209); and a 25K sq. ft. Class 100,000 clean room (FED-STD-209); and 39 laminar flow hoods provide Class 100 work areas.
Solitron’s customers include Lockheed Martin, Honeywell, BAE Systems, Raytheon, and General Dynamics. Customers also include Northrop Grumman, GE, Boeing, and L3 Communications.
Solitron Devices, Inc. (SODI), closed Wednesday's trading session at $4.22, up 0.48%, on 18,000 volume with 3 trades. The average volume for the last 60 days is 5,695 and the stock's 52-week low/high is $3.21/$4.20.
MamaMancini's Holdings, Inc. (MMMB)
Marketbeat, TaglichBrothers, Stock News Now, OTC Markets Group, SmallCapVoice, and TheMicrocapNews reported earlier on MamaMancini's Holdings, Inc. (MMMB), and we also report on the Company, here at the QualityStocks Daily Newsletter.
MamaMancini's Holdings, Inc. is a marketer of specialty pre-prepared, frozen, and refrigerated all natural food products (as defined by the United States Department of Agriculture - USDA). The Company is a marketer and distributor of a line of beef meatballs with sauce, turkey meatballs with sauce, chicken meatballs with sauce, and pork meatballs with sauce, along with other similar Italian products. MamaMancini’s Holdings is headquartered in East Rutherford, New Jersey.
The Company offers Slow Cooked Italian Sauce and Meatballs, Stuffed Meatballs, Slow Cooked Sauces, Slow Cooked "Italian Style Sauce" and Meatballs - Gluten Free, Slow Cooked Italian Sauce and Meatballs made without Antibiotics, and its Italian Style Meatloaf. In addition, MamaMancini's has Food Service offerings and offers Bulk Deli Orders.
MamaMancini's distribution channel includes major retailers, including Costco, Sams Clubs, Publix, Shop Rite, Price Chopper, Harris Teeter, SaveMarts, Luckys, Lunds/Byerly's, SuperValu, Raley's, BJ's, Whole Foods, Shaw's Supermarkets, Kings, Key Foods, and Stop-n-Shop. Additionally, the Company’s distribution channel includes Giant Stores, Giant Eagle, King Kullen, Food Town, Kroger, Safeway, Albertsons, Lowes, Nash Finch, Spartan Stores, Shoppers, Marsh's Supermarkets, Central Markets, Weis Markets, Ingles, Market Basket, Roche Brothers, and The Fresh Market.
Two new MamaMancini's products include All-Beef Florentine Five Cheese and Spinach Stuffed Meatballs in authentic Italian sauce; and Chicken Florentine Five Cheese and Spinach Stuffed Meatballs in authentic Italian sauce. Both products offer convenience in preparation and have a first-rate nutritional profile.
Last month, MamaMancini's Holdings announced financial results for Q3 of fiscal year 2017, ended October 31, 2016. Q3 2017 highlights include revenue increasing 41 percent to $4.6 million versus Q3 2016 revenue of $3.2 million. Q3 2017 gross margin grew to 37 percent versus 30 percent in Q3 of fiscal 2016.
Income from operations for Q3 fiscal 2017 improved to $243,563 in comparison to $(358,159) in the year ago Q3. This represents an increase of over $600,000. Net income for Q3 fiscal 2017 improved to $80,603 versus $(975,522) in Q3 of fiscal 2016.
MamaMancini's Holdings, Inc. (MMMB), closed Wednesday's trading session at $0.65, even for the day, on 14,581 volume with 5 trades. The average volume for the last 60 days is 6,972 and the stock's 52-week low/high is $0.31/$0.85.
The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX). Today, ChineseInvestors.com closed trading at $2.38, off by 6.67%, on 466,537 volume with 709 trades. The stock’s average daily volume over the past 60 days is 121,884 and its 52-week low/high is $0.12/$2.69.
ChineseInvestors.com, Inc., the premier financial information website for Chinese-speaking investors in both the U.S. and China, announces that it has engaged the expertise of NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. NNW's solutions help public and private organizations find their voice and build market visibility via social media and a rapidly expanding distribution network of well over 5,000 key syndication outlets.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer
ChineseInvestors.com, Inc. (CIIX) Engages NetworkNewsWire for Corporate Communications Solutions
Covered in New Report from WallStreet Research™
ChineseInvestors.com Announces the Location of the new Headquarters for www.ChineseCBDoil.com, the World's First CBD Health Products Online Store in the Chinese Language
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.042005, up 31.27%, on 18,967,018 volume with 800 trades. The stock’s average daily volume over the past 60 days is 4,879,152, and its 52-week low/high is $0.0046/$0.0503.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
Mounting Support for Marijuana Banking Has Widespread Implications
Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry
SinglePoint Subsidiary: Opportunities High Amid Congressional Call for Cannabis Banking Reform
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.42, up 0.59%, on 7,982 volume with 12 trades. The stock’s average daily volume over the past 60 days is 10,564, and its 52-week low/high is $0.697/$5.84.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp Realty Nearly Triples Agent Count in 2016
eXp World Holdings, Inc. Announces Appointment of Independent Director
eXp World Holdings, Inc. Retains MZ Group as its Investor Relations Advisor
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.28, off by 12.31%, on 12,263 volume with 25 trades. The stock’s average daily volume over the past 60 days is 8,774, and its 52-week low/high is $1.10/$5.00.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
Monaker Group Shareholder Update -- 2016 Milestones and Transactional Business
Monaker Group (MKGI): Tip of the Travel Industry Iceberg -- SECFilings.com
GainClients, Inc. (GCLT)
The QualityStocks Daily Newsletter would like to spotlight GainClients, Inc. (GCLT). Today, GainClients, Inc. closed trading at $0.0251, off by 26.18%, on 95,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 130,189, and its 52-week low/high is $0.01/$0.20.
GainClients, Inc. (GCLT) is a software service company focused primarily on the development of marketing services for real estate professionals and valuable home search and area information tools for consumers. The company's innovations expound the popularity of online networks by helping real estate professionals better serve their clients through the sharing of accurate real estate data.
The company's main product is the GCard progressive networking system, which is designed to build and promote relationships among real estate professionals and their clients. Using the GCard, agents and brokers have the means to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions.
Similar to the features of other popular online networks, professional users can invite clients and their industry partners to join their GCard networks and be featured as trusted team members. From here, the teams can quickly provide real estate, lending and title services and information to consumers via smartphone and web. With better communication throughout the process of buying or selling homes, purchases can move more quickly and more comfortably to completion.
Strategic partnerships are an important component of GainClients' growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies' proprietary technologies to the real estate industry. CLOVIS will use GainClients' GCard to develop a unique lead generation program for the broader real estate marketing and advertising industry.
GainClients also offers GCHomeSearch, its stand-alone website that provides non-real estate customers, such as lenders and title professionals, with accurate listing data, historical property data, neighborhood information and demographics. When used with the GCard, the user is also privy to loan payment calculators, loan rates, closing cost estimators and other tools needed to make intelligent buying and selling choices. Disclaimer
GainClients, Inc. Company Blog
GainClients, Inc. News:
GainClients, Inc. Retains Largest Real Estate Customer on its GCard Service
GainClients, Inc. Announces Corporate Update
GainClients, Inc. Enters Into A Licensing Agreement with Real Estate Technology Upstart CLOVIS, LLC To Expand Its Technology Platform
Today's Top 3
Damn Good Penny Picks
The QualityStocks Public Company Sponsor News